Accrol Group Holdings plc (the “Company” or “Accrol”), the AIM-listed leading independent tissue converter, notes that the open offer to raise up to £1.935 million described in the announcement dated 22 May 2018 titled “Open Offer” (the “Open Offer”) closed for acceptances at 11.00 a.m. on 6 June 2018 in accordance with its terms. The Company reports that it has received valid applications in respect of a total of 37,108,972 new ordinary shares of £0.001 in the Company (“New Ordinary Shares”), representing a percentage take up of 287.64 per cent. of the New Ordinary Shares available under the Open Offer….